Back to Trials
NCT06595407RecruitingAccepts Healthy Volunteers

Loss of Y Chromosome in Aortic Stenosis

University of Virginia

Start Date

8/15/2024

Completion Date

6/1/2026

Summary

The most common heart valve disease in humans is aortic stenosis which is a critical narrowing of the valve through which the heart has to pump blood to the rest of the body. This condition occurs in 2-3% of adults over 65 years of age and when it progresses to a severe stage leads to heart failure and need for valve replacement procedures (including surgery and catheter-based replacement). Aortic stenosis has a strong male predominance. The purpose of this study is to evaluate whether loss of Y-chromosome from circulating blood cells in males, which has been associated with TGF-beta-related fibrosis of other organs, is associated with the development of aortic stenosis.

Eligibility Criteria

Age Range: 40 years to No maximum

Inclusion Criteria: * Aortic stenosis (valve area \<1.5cm2) Exclusion Criteria: * Bicuspid aortic valve * History of radiation to chest * Inflammatory (autoimmune, rheumatologic) disease associated with aortic stenosis * Active cancer

Interventions

DIAGNOSTIC_TEST

Blood analysis for loss-of-Y chromosome

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Aortic Stenosis

Locations

University of Virginia

Charlottesville, Virginia 22903

United States